ArticleRadiology case reports2026
Fahr syndrome in an 18-year-old male with pseudohypoparathyroidism: Clinical-radiological dissociation.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fahr syndrome, characterized by bilateral intracranial calcifications, is a rare but clinically significant complication of chronic calcium-phosphate dysregulation in pseudohypoparathyroidism (PHP). Clinical manifestations frequently do not correlate with the extent of radiological findings, posing diagnostic challenges. An 18-year-old male with longstanding PHP presented with occipital headaches, carpopedal spasms, and depressed mood following more than two weeks of medication non-compliance. Non-contrast computed tomography (CT) of the brain confirmed extensive bilateral calcifications involving the basal ganglia, thalami, dentate nuclei, and subcortical white matter, with supportive findings on magnetic resonance imaging (MRI), including T1 hypointensity, variable T2 signal, and marked blooming artifact on susceptibility-weighted imaging (SWI). Neurological examination was largely unremarkable. Laboratory evaluation revealed hypocalcemia (serum calcium 7.2 mg/dL) with elevated intact parathyroid hormone (137 pg/mL), consistent with end-organ PTH resistance; serum phosphate (4.2 mg/dL) and 25-hydroxyvitamin D (42.4 ng/mL) were within the normal range. Electroencephalography showed no epileptiform activity. Optimization of calcium and calcitriol supplementation, together with symptomatic treatment, resulted in resolution of carpopedal spasms and significant improvement in headaches and mood at 15-day follow-up. This case illustrates the marked clinical-radiological dissociation characteristic of Fahr syndrome. Neurological evaluation or neuroimaging should be considered in PHP patients who develop new neurological or neuropsychiatric symptoms, particularly in the setting of poor biochemical control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.